Sumitomo Pharma Co., Ltd. (DNPUF)
9.27
+0.86
(+10.29%)
USD |
OTCM |
Aug 25, 16:00
Sumitomo Pharma Total Assets (Quarterly) : 5.198B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.198B |
| March 31, 2026 | 5.057B |
| December 31, 2025 | 5.203B |
| September 30, 2025 | 5.271B |
| June 30, 2025 | 5.077B |
| March 31, 2025 | 4.966B |
| December 31, 2024 | 5.422B |
| September 30, 2024 | 5.591B |
| June 30, 2024 | 5.402B |
| March 31, 2024 | 5.996B |
| December 31, 2023 | 7.519B |
| September 30, 2023 | 7.699B |
| June 30, 2023 | 7.892B |
| March 31, 2023 | 8.526B |
| December 31, 2022 | 10.39B |
| September 30, 2022 | 9.727B |
| June 30, 2022 | 10.47B |
| March 31, 2022 | 10.78B |
| December 31, 2021 | 11.25B |
| September 30, 2021 | 11.36B |
| June 30, 2021 | 11.50B |
| March 31, 2021 | 11.84B |
| December 31, 2020 | 12.68B |
| September 30, 2020 | 11.74B |
| June 30, 2020 | 11.46B |
| Date | Value |
|---|---|
| March 31, 2020 | 11.64B |
| December 31, 2019 | 10.26B |
| September 30, 2019 | 7.449B |
| June 30, 2019 | 7.500B |
| March 31, 2019 | 7.541B |
| December 31, 2018 | 7.566B |
| September 30, 2018 | 7.364B |
| June 30, 2018 | 7.405B |
| March 31, 2018 | |
| December 31, 2017 | 7.473B |
| September 30, 2017 | 7.361B |
| June 30, 2017 | 7.196B |
| March 31, 2017 | 7.125B |
| December 31, 2016 | 6.438B |
| September 30, 2016 | 6.331B |
| June 30, 2016 | 6.415B |
| March 31, 2016 | 6.297B |
| December 31, 2015 | 6.290B |
| September 30, 2015 | 6.062B |
| June 30, 2015 | 5.944B |
| March 31, 2015 | 5.934B |
| December 31, 2014 | 5.979B |
| September 30, 2014 | 6.115B |
| June 30, 2014 | 6.302B |
| March 31, 2014 | 6.399B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 96.37B |
| Daiichi Sankyo Co., Ltd. | 25.32B |
| Eisai Co., Ltd. | 9.587B |
| Chugai Pharmaceutical Co., Ltd. | 15.07B |
| Santen Pharmaceutical Co., Ltd. | 2.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.685B |
| Shareholders Equity (Quarterly) | 2.514B |
| Debt to Equity Ratio | 0.3932 |
| Current Ratio | 1.212 |
| Net Debt Paydown Yield | 5.27% |